Some breast tumors metastasize aggressively whereas others remain dormant for years. The mechanism governing metastatic dormancy remains largely unknown. Through high-parametric single-cell mapping in mice, we identify a discrete population of CD39PD-1CD8 T cells in primary tumors and in dormant metastasis, which is hardly found in aggressively metastasizing tumors. Using blocking antibodies, we find that dormancy depends on TNFα and IFNγ. Immunotherapy reduces the number of dormant cancer cells in the lungs. Adoptive transfer of purified CD39PD-1CD8 T cells prevents metastatic outgrowth. In human breast cancer, the frequency of CD39PD-1CD8 but not total CD8 T cells correlates with delayed metastatic relapse after resection (disease-free survival), thus underlining the biological relevance of CD39PD-1CD8 T cells for controlling experimental and human breast cancer. Thus, we suggest that a primary breast tumor could prime a systemic, CD39PD-1CD8 T cell response that favors metastatic dormancy in the lungs.